Esomeprazole Magnesium For Suspension
Product Images NDC 69097-508

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 69097-508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Unit Dose Package 2.5mg (Unit Dose 2 5mg)

Unit Dose Package 2.5mg (Unit Dose 2 5mg)
FDA Label Image

Unit Dose Package 5 mg (Unit Dose 5mg)

Unit Dose Package 5 mg (Unit Dose 5mg)
This description mentions Esomeprazole Magnesium for delayed-release oral suspension. Esomeprazole Magnesium is commonly used to treat heartburn, a condition caused by stomach acid flowing back into the food pipe. The delayed-release formulation ensures the medication works effectively by releasing it in the intestine rather than the stomach. This text is focused on a specific formulation of the medication available in oral suspension form for ease of administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.